News & Events
News & Events
Biotalk Episode 9 2023 Q3 Report: Global Trends in Biopharma Transactions
During this episode of Biotalk, Geoff Meyerson, CEO of Locust Walk, delves into our 2023 Q3 Report: Global Trends in Biopharma Transactions Report. Each quarter, Locust Walk’s deal team compiles key statistics and trends showcasing the current state of global private...
2023 Q3 Report: Global Trends in Biopharma Transactions
Each quarter, Locust Walk’s deal team compiles key statistics and trends on strategic transactions and financings. Our 2023 Third Quarter Report applies the latest data to analyze current activities in the life sciences deal landscape.
Biotalk Episode 8: A Conversation with Helen Ho of Blueprint Medicines
On this episode of Biotalk, Locust Walk's Andy Meyerson welcomes Helen Ho, Chief Business Officer of Blueprint Medicines, to the podcast. Blueprint Medicines is a pioneering global precision therapy company committed to crafting life-altering medications for...
Biotalk Episode 7: A Conversation with Howard Federoff of Ryne Biotechnology
On this episode of Biotalk, Locust Walk's Geoff Meyerson welcomes Howard Federoff, MD PhD, Scientific Co-Founder, Chief Medical Officer, and Director of Ryne Biotechnology, to the podcast. Join us as we delve into Ryne Bio's pioneering work centered on advancing...
Biotalk Episode 6: A Conversation with Jason Kelly
On this episode of Biotalk, Locust Walk’s Andy Meyerson welcomes Jason Kelly, co-Founder and CEO of Ginkgo Bioworks, to the podcast. Ginkgo Bioworks is at the forefront of genetic engineering, harnessing its power to craft bacteria with industrial applications, which...
Biotalk Episode 5: A Conversation with Onaiza Cadoret-Manier
On this episode of Biotalk, Locust Walk's Geoff Meyerson welcomes Onaiza Cadoret-Manier, Executive Vice President, Chief Global Product Strategy & Operations Officer at Ionis Pharmaceuticals to the podcast. With 30 years of experience in life sciences, Onaiza is a...